Qin H H, Xing Z F, Wang X F, Ding Q L, Xi X D, Wang H L
State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai, China; Department of Laboratory Medicine, Shanghai 9th Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai, China.
Blood Cells Mol Dis. 2014 Apr;52(4):181-5. doi: 10.1016/j.bcmd.2013.11.005. Epub 2013 Dec 16.
In this study, we investigated the molecular basis of two unrelated Chinese patients with hemostatic disorders. The proband of the first family had severe hemophilia A (HA) coexisting with type 1 von Willebrand disease (VWD) and the proband of the second family had type 2N VWD. Both probands had similar phenotypes, which included joint and mucosal bleeding, very low factor VIII (FVIII) activity (FVIII:C), and moderate reductions in VWF antigen (VWF:Ag) and VWF ristocetin cofactor activity (VWF:Rco), as well as a normal multimeric pattern. One FVIII mutation and three VWF mutations were identified: FVIII p.R446* and VWF heterozygous p.E216K mutations were detected in proband 1 and compound heterozygosity of VWF mutations (p.R816W and c.1911delC) in proband 2. Transient expression studies in HEK293T cells proved that R816W mutation abolished the binding of FVIII to VWF and slightly impaired protein synthesis and secretion; 1911delC mutation mainly impaired VWF protein synthesis and secretion. These results provided insight into the possible pathogenic mechanism of type 2N VWD in Chinese patients carrying these mutations.
在本研究中,我们调查了两名患有止血障碍的中国非亲缘患者的分子基础。第一个家系的先证者患有严重血友病A(HA)并伴有1型血管性血友病(VWD),第二个家系的先证者患有2N型VWD。两名先证者具有相似的表型,包括关节和黏膜出血、极低的凝血因子VIII(FVIII)活性(FVIII:C)、血管性血友病因子抗原(VWF:Ag)和血管性血友病因子瑞斯托霉素辅因子活性(VWF:Rco)中度降低,以及正常的多聚体模式。鉴定出一个FVIII突变和三个VWF突变:在先证者1中检测到FVIII p.R446*和VWF杂合p.E216K突变,在先证者2中检测到VWF突变(p.R816W和c.1911delC)的复合杂合性。在HEK293T细胞中的瞬时表达研究证明,R816W突变消除了FVIII与VWF的结合,并轻微损害了蛋白质合成和分泌;1911delC突变主要损害VWF蛋白质合成和分泌。这些结果为携带这些突变的中国患者中2N型VWD的可能致病机制提供了见解。